Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: BWAC who wrote (2514)	2/16/1999 8:18:00 PM
From: Joe Dancy	Read Replies (1) \| Respond to of 2553

For what it is worth, maybe not much, Michael Murphy of the Cal Tech letter recently did an interview with SI's Mark Johnson, and Murphy was bullish on biotechs in 1999. He thought that the number of drugs approved would increase substantially from last year, some companies would turn a profit that to date have not, and that the FDA was very in tune with getting drugs moved through the approval process. FWIW, Johnson's interview with Murphy is at audioinvestor.com